Susan Kalled
Equibles does not estimate personal net worth.
About Susan Kalled
The proxy statement of Compass Therapeutics, Inc. reports total compensation of $462,030 for Susan Kalled in fiscal 2022, including a base salary of $297,500. Disclosed compensation is on record for 3 fiscal years.
Affiliation history
-
Compass Therapeutics, Inc. (CMPX)
Proxy statement
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Compass Therapeutics, Inc. (CMPX) | Chief Scientific Officer | $297,500 | $462,030 |
| 2021 | Compass Therapeutics, Inc. (CMPX) | Chief Scientific Officer | $220,000 | $1,781,616 |
| 2020 | Compass Therapeutics, Inc. (CMPX) | Chief Scientific Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.